Treatment of pityriasis rubra pilaris with ustekinumab.
Wohlrab
J
J
Kreft
B
B
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001706:Biopsy; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D010916:Pityriasis Rubra Pilaris / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome; D000069549:Ustekinumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; D007155:Immunologic Factors; D000069549:Ustekinumab